サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1609861

日本の3Dバイオプリンティング市場レポート：コンポーネント、用途、エンドユーザー、地域別、2025年～2033年

Japan 3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 122 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
日本の3Dバイオプリンティング市場レポート：コンポーネント、用途、エンドユーザー、地域別、2025年～2033年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 122 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の3Dバイオプリンティング市場の市場規模は2024年に8,290万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに3億1,670万米ドルに達し、2025年から2033年にかけて16.1%の成長率（CAGR）を示すと予測しています。老年人口における臓器移植ニーズの高まりと、医療技術への容易なアクセスが、主に市場成長の原動力となっています。

本レポートで扱う主な質問

  • 日本の3Dバイオプリンティング市場はこれまでどのように推移し、今後どのように推移するのか？
  • 日本の3Dバイオプリンティング市場にCOVID-19が与えた影響は？
  • 日本の3Dバイオプリンティング市場のコンポーネント別の内訳は？
  • 日本の3Dバイオプリンティング市場の用途別の内訳は？
  • 日本の3Dバイオプリンティング市場のエンドユーザー別の内訳は？
  • 日本の3Dバイオプリンティング市場のバリューチェーンにはどのような段階がありますか？
  • 日本の3Dバイオプリンティングにおける主な促進要因と課題は？
  • 日本の3Dバイオプリンティング市場の構造と主要プレーヤーは？
  • 日本の3Dバイオプリンティング市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の3Dバイオプリンティング市場：イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の3Dバイオプリンティング市場情勢

  • 過去および現在の市場動向（2019年～2024年）
  • 市場予測（2025-2033）

第6章 日本の3Dバイオプリンティング市場：コンポーネント別の内訳

  • 3Dバイオプリンター
  • スキャフォルド
  • 生体材料

第7章 日本の3Dバイオプリンティング市場：用途別の内訳

  • 研究
  • 臨床

第8章 日本の3Dバイオプリンティング市場：エンドユーザー別の内訳

  • 病院
  • 研究機関および学術機関
  • バイオ医薬品企業

第8章 日本の3Dバイオプリンティング市場：競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第9章 主要企業のプロファイル

第10章 日本の3Dバイオプリンティング市場：業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第11章 付録

目次
Product Code: SR112024A18261

Japan 3D bioprinting market size reached USD 82.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 316.7 Million by 2033, exhibiting a growth rate (CAGR) of 16.1% during 2025-2033. The elevating need for organ transplantation among the geriatric population, along with the easy access to medical technologies, is primarily driving the market growth.

Three-dimensional (3D) bioprinting is an additive manufacturing technique developed for the precise fabrication of anatomical tissues. This method encompasses various deposition and assembly processes, including direct and laser writing, microstamping, photolithography, stereolithography, electro-printing, and inkjet deposition. In addition to this, it relies on the layer-by-layer assembly of cell-based bio-inks, which are formulated using living cells, biomaterials, and active biomolecules, to construct 3D tissue and organ structures. By depositing multiple layers of biomaterials, 3D bioprinting can create complex bodily structures such as bones, skin, cartilage, vascular grafts, tracheal splints, and heart tissues. Consequently, it finds extensive applications in hospitals, research institutions, academic establishments, and biopharmaceutical companies across Japan.

Japan 3D Bioprinting Market Trends:

In the context of the Japan market, the increasing emphasis on reducing animal testing is a significant factor positively influencing the industry. Additionally, the rising demand for 3D bioprinting, particularly among the elderly population who are more susceptible to various chronic illnesses, is fostering a favorable market outlook, thereby acting as another significant growth-inducing factor. Besides this, technological advancements such as the development of organ-on-a-chip systems are also driving market growth. Furthermore, the surging global demand for regenerative medicines, cancer therapeutics, and stem cell solutions is contributing to the expansion of the market. Apart from this, the healthcare sector in Japan is increasingly adopting 3D bioprinting, and its relatively lower disruption level compared to other industries is providing substantial support to market growth. Moreover, prominent manufacturers are placing a strong focus on research and development (R&D) activities aimed at introducing bio printed tissues, which is positively influencing the regional market. This effort aims to reduce the cost associated with new innovations and streamline the drug discovery process, further propelling advancement within Japan. All these above mentioned factors are expected to catalyze the market growth over the forecasted period.

Japan 3D Bioprinting Market Segmentation:

Component Insights:

  • 3D Bioprinters
  • Syringe/Extrusion Bioprinting
  • Inkjet Bioprinting
  • Magnetic Levitation Bioprinting
  • Laser-assisted Bioprinting
  • Others
  • Scaffolds
  • Biomaterials
  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Others

Application Insights:

  • Research
  • Drug Research
  • Regenerative Medicine
  • 3D Cell Culture
  • Clinical
  • Skin
  • Bone and Cartilage
  • Blood Vessels
  • Others

End User Insights:

  • Hospitals
  • Research Organization and Academic Institutes
  • Biopharmaceuticals Companies

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan 3D bioprinting market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan 3D bioprinting market?
  • What is the breakup of the Japan 3D bioprinting market on the basis of component?
  • What is the breakup of the Japan 3D bioprinting market on the basis of application?
  • What is the breakup of the Japan 3D bioprinting market on the basis of end user?
  • What are the various stages in the value chain of the Japan 3D bioprinting market?
  • What are the key driving factors and challenges in the Japan 3D bioprinting?
  • What is the structure of the Japan 3D bioprinting market and who are the key players?
  • What is the degree of competition in the Japan 3D Bioprinting market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan 3D Bioprinting Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan 3D Bioprinting Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan 3D Bioprinting Market - Breakup by Component

  • 6.1 3D Bioprinters
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Syringe/Extrusion Bioprinting
      • 6.1.3.2 Inkjet Bioprinting
      • 6.1.3.3 Magnetic Levitation Bioprinting
      • 6.1.3.4 Laser-assisted Bioprinting
      • 6.1.3.5 Others
    • 6.1.4 Market Forecast (2025-2033)
  • 6.2 Scaffolds
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Biomaterials
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Segmentation
      • 6.3.3.1 Living Cells
      • 6.3.3.2 Hydrogels
      • 6.3.3.3 Extracellular Matrices
      • 6.3.3.4 Others
    • 6.3.4 Market Forecast (2025-2033)

7 Japan 3D Bioprinting Market - Breakup by Application

  • 7.1 Research
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Segmentation
      • 7.1.3.1 Drug Research
      • 7.1.3.2 Regenerative Medicine
      • 7.1.3.3 3D Cell Culture
    • 7.1.4 Market Forecast (2025-2033)
  • 7.2 Clinical
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Segmentation
      • 7.2.3.1 Skin
      • 7.2.3.2 Bone and Cartilage
      • 7.2.3.3 Blood Vessels
      • 7.2.3.4 Others
    • 7.2.4 Market Forecast (2025-2033)

8 Japan 3D Bioprinting Market - Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Research Organization and Academic Institutes
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Biopharmaceuticals Companies
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)

8 Japan 3D Bioprinting Market - Competitive Landscape

  • 8.1 Overview
  • 8.2 Market Structure
  • 8.3 Market Player Positioning
  • 8.4 Top Winning Strategies
  • 8.5 Competitive Dashboard
  • 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

  • 9.1 Company A
    • 9.1.1 Business Overview
    • 9.1.2 Product Portfolio
    • 9.1.3 Business Strategies
    • 9.1.4 SWOT Analysis
    • 9.1.5 Major News and Events
  • 9.2 Company B
    • 9.2.1 Business Overview
    • 9.2.2 Product Portfolio
    • 9.2.3 Business Strategies
    • 9.2.4 SWOT Analysis
    • 9.2.5 Major News and Events
  • 9.3 Company C
    • 9.3.1 Business Overview
    • 9.3.2 Product Portfolio
    • 9.3.3 Business Strategies
    • 9.3.4 SWOT Analysis
    • 9.3.5 Major News and Events
  • 9.4 Company D
    • 9.4.1 Business Overview
    • 9.4.2 Product Portfolio
    • 9.4.3 Business Strategies
    • 9.4.4 SWOT Analysis
    • 9.4.5 Major News and Events
  • 9.5 Company E
    • 9.5.1 Business Overview
    • 9.5.2 Product Portfolio
    • 9.5.3 Business Strategies
    • 9.5.4 SWOT Analysis
    • 9.5.5 Major News and Events

10 Japan 3D Bioprinting Market - Industry Analysis

  • 10.1 Drivers, Restraints, and Opportunities
    • 10.1.1 Overview
    • 10.1.2 Drivers
    • 10.1.3 Restraints
    • 10.1.4 Opportunities
  • 10.2 Porters Five Forces Analysis
    • 10.2.1 Overview
    • 10.2.2 Bargaining Power of Buyers
    • 10.2.3 Bargaining Power of Suppliers
    • 10.2.4 Degree of Competition
    • 10.2.5 Threat of New Entrants
    • 10.2.6 Threat of Substitutes
  • 10.3 Value Chain Analysis

11 Appendix